Literature DB >> 21415930

Differential effects of specific amino acid restriction on glucose metabolism, reduction/oxidation status and mitochondrial damage in DU145 and PC3 prostate cancer cells.

Xiaoyi Liu1, Ya-Min Fu, Gary G Meadows.   

Abstract

Selective amino acid restriction targets mitochondria to induce apoptosis of DU145 and PC3 prostate cancer cells. Biochemical assays and flow cytometry were uitilized to analyze the glucose consumption, lactate production, pyruvate dehydrogenase (PDH), nicotinamide adenine dinucleotide (NAD)/NADH and nicotinamide adenine dinucleotide phosphate (NADP)/NADPH ratios, mitochondrial glutathione peroxidase (GPx), manganese superoxide dismutase (SOD), glutathione, reactive oxygen species (ROS) and DNA damage in DU145 and PC prostate cancer cells cultured under various amino acid deprived conditions. Restriction of tyrosine and phenylalanine (Tyr/Phe), glutamine (Gln) or methionine (Met) differentially modulated glucose metabolism and PDH and antioxidant enzyme activity in the mitochondria of the two prostate cancer cell lines. In DU145 cells, Gln and Met restriction increased glucose consumption and decreased lactate production, but Tyr/Phe restriction did not. The examined restrictions increased mitochondrial PDH activity and accumulation of ROS. Gln and Met restriction increased GPx activity. Tyr/Phe and Met restriction increased SOD during the first 2 days of the restriction, and the activity returned to the basal level on day 4. All amino acid restrictions decreased reduced glutathione (GSH) and induced mitochondrial DNA damage. In PC3 cells, all amino acid restrictions reduced glucose consumption and lactate production. Gln restriction increased ROS and elevated GPx activity. Tyr/Phe restriction increased SOD activity. The amino acid restriction decreased GSH, but did not cause mitochondrial DNA damage. Specific amino acid dependency differentially regulates glucose metabolism, oxidation-reduction reactions of mitochondria and mitochondrial damage in DU145 and PC3 prostate cancer cell lines.

Entities:  

Year:  2011        PMID: 21415930      PMCID: PMC3057076          DOI: 10.3892/ol.2011.237

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  18 in total

Review 1.  Mitochondria and apoptosis.

Authors:  D R Green; J C Reed
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

Review 2.  Apoptosis, tumour invasion and prostate cancer.

Authors:  M Tenniswood
Journal:  Br J Urol       Date:  1997-04

3.  Selective amino acid restriction targets mitochondria to induce apoptosis of androgen-independent prostate cancer cells.

Authors:  Ya-Min Fu; Hui Zhang; Mingjie Ding; Yi-Qi Li; Xing Fu; Zu-Xi Yu; Gary G Meadows
Journal:  J Cell Physiol       Date:  2006-11       Impact factor: 6.384

Review 4.  Mitochondria as therapeutic targets for cancer chemotherapy.

Authors:  L Galluzzi; N Larochette; N Zamzami; G Kroemer
Journal:  Oncogene       Date:  2006-08-07       Impact factor: 9.867

5.  Role for mitochondrial oxidants as regulators of cellular metabolism.

Authors:  S Nemoto; K Takeda; Z X Yu; V J Ferrans; T Finkel
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

6.  Bcl-2 and Mn-SOD antisense oligodeoxynucleotides and a glutamine-enriched diet facilitate elimination of highly resistant B16 melanoma cells by tumor necrosis factor-alpha and chemotherapy.

Authors:  María Benlloch; Salvador Mena; Paula Ferrer; Elena Obrador; Miguel Asensi; José A Pellicer; Julian Carretero; Angel Ortega; José M Estrela
Journal:  J Biol Chem       Date:  2005-11-01       Impact factor: 5.157

Review 7.  Mitochondrial diseases in man and mouse.

Authors:  D C Wallace
Journal:  Science       Date:  1999-03-05       Impact factor: 47.728

8.  Focal adhesion kinase-dependent apoptosis of melanoma induced by tyrosine and phenylalanine deficiency.

Authors:  Y M Fu; Z X Yu; B A Pelayo; V J Ferrans; G G Meadows
Journal:  Cancer Res       Date:  1999-02-01       Impact factor: 12.701

Review 9.  Molecular regulation of angiogenesis and tumorigenesis by signal transduction pathways: evidence of predictable and reproducible patterns of synergy in diverse neoplasms.

Authors:  Jack L Arbiser
Journal:  Semin Cancer Biol       Date:  2004-04       Impact factor: 15.707

Review 10.  Mitochondrial defects in cancer.

Authors:  Jennifer S Carew; Peng Huang
Journal:  Mol Cancer       Date:  2002-12-09       Impact factor: 27.401

View more
  8 in total

Review 1.  Lipids and prostate cancer.

Authors:  Janel Suburu; Yong Q Chen
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-04-05       Impact factor: 3.072

Review 2.  The fat side of prostate cancer.

Authors:  Giorgia Zadra; Cornelia Photopoulos; Massimo Loda
Journal:  Biochim Biophys Acta       Date:  2013-04-02

3.  Multiple metabolic alterations exist in mutant PI3K cancers, but only glucose is essential as a nutrient source.

Authors:  Rebecca Foster; Sue Griffin; Suzanne Grooby; Ruth Feltell; Cindy Christopherson; Monica Chang; John Sninsky; Shirley Kwok; Chris Torrance
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

4.  Glutamine promotes ovarian cancer cell proliferation through the mTOR/S6 pathway.

Authors:  Lingqin Yuan; Xiugui Sheng; Adam K Willson; Dario R Roque; Jessica E Stine; Hui Guo; Hannah M Jones; Chunxiao Zhou; Victoria L Bae-Jump
Journal:  Endocr Relat Cancer       Date:  2015-06-04       Impact factor: 5.678

5.  Identification of key DNA methylation-driven genes in prostate adenocarcinoma: an integrative analysis of TCGA methylation data.

Authors:  Ning Xu; Yu-Peng Wu; Zhi-Bin Ke; Ying-Chun Liang; Hai Cai; Wen-Ting Su; Xuan Tao; Shao-Hao Chen; Qing-Shui Zheng; Yong Wei; Xue-Yi Xue
Journal:  J Transl Med       Date:  2019-09-18       Impact factor: 5.531

Review 6.  Hormone-Glutamine Metabolism: A Critical Regulatory Axis in Endocrine-Related Cancers.

Authors:  Fengyuan Xu; Jialu Shi; Xueyun Qin; Zimeng Zheng; Min Chen; Zhi Lin; Jiangfeng Ye; Mingqing Li
Journal:  Int J Mol Sci       Date:  2022-09-03       Impact factor: 6.208

7.  Subpathway-CorSP: Identification of metabolic subpathways via integrating expression correlations and topological features between metabolites and genes of interest within pathways.

Authors:  Chenchen Feng; Jian Zhang; Xuecang Li; Bo Ai; Junwei Han; Qiuyu Wang; Taiming Wei; Yong Xu; Meng Li; Shang Li; Chao Song; Chunquan Li
Journal:  Sci Rep       Date:  2016-09-14       Impact factor: 4.379

8.  Cell metabolomics to study the function mechanism of Cyperus rotundus L. on triple-negative breast cancer cells.

Authors:  Shuangshuang Ma; Fukai Wang; Caijuan Zhang; Xinzhao Wang; Xueyong Wang; Zhiyong Yu
Journal:  BMC Complement Med Ther       Date:  2020-08-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.